1. The “new wave” of antidepressants: are these agents paradigm-shifters in treating major depression?
   B. Petrescu et al, 2023, Psihiatru.ro CrossRef
2. Perioperative esketamine administration for prevention of postpartum depression after the cesarean section: A systematic review and meta-analysis
   Mohammadamin Parsaei et al, 2024, Journal of Affective Disorders CrossRef
3. Exploring the Comorbidity, Pathophysiology, and Integrated Treatment Strategies of Hypertension and Depression
   Nicholas A. Kerna et al, 2024, European Journal of Medical and Health Research CrossRef
4. Current evidence and future perspectives in the exploration of sleep-related eating disorder–a systematic literature review
   Octavian Vasiliu, 2024, Frontiers in Psychiatry CrossRef
5. Supplemental low-dose esketamine to propofol versus propofol alone on perioperative characteristics in children undergoing surgery: a prospective randomized controlled trial
   Ding HAN et al, 2024, Minerva Anestesiologica CrossRef
6. Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review
   Suneeta Kumari et al, 2024, Cureus CrossRef
7. Ketamine and Transcranial Magnetic Stimulation in an Adolescent with Treatment-Resistant Depression
   Aarti U. Jerath et al, 2023, Journal of Child and Adolescent Psychopharmacology CrossRef
8. Baseline characteristics of a European patient population with difficult-to-treat depression (RESTORE-LIFE) treated with adjunctive vagus nerve stimulation
   Koen Demyttenaere et al, 2024, Journal of Affective Disorders CrossRef
9. Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
   Jéssica L. Antunes et al, 2023, Pharmaceutics CrossRef
10. New Light on Prions: Putative Role of PrPc in Pathophysiology of Mood Disorders
    Adrian Andrzej Chrobak et al, 2024, International Journal of Molecular Sciences CrossRef
11. Illuminating the way: the role of bright light therapy in the treatment of depression
    Biljana Kosanovic Rajacic et al, 2023, Expert Review of Neurotherapeutics CrossRef
12. Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
    Asmita Deka Dey et al, 2024, Psychopharmacology CrossRef
13. Impact of Adjunctive VNS on Drug Load, Depression Severity, and Number of Neuromodulatory Maintenance Treatments
    Erhan Kavakbasi et al, 2024, Brain Sciences CrossRef
14. Preclinical models of treatment-resistant depression: challenges and perspectives
    Magdalena Kolasa et al, 2023, Pharmacological Reports CrossRef
15. Overcoming treatment gaps in the management of depression with non-pharmacological adjunctive strategies
    György Purebl et al, 2023, Frontiers in Psychiatry CrossRef
16. Esketamine Inhibits Cocaine-Seeking Behaviour Subsequent to Various Abstinence Conditions in Rats
    Karolina Wydra et al, 2023, Biomolecules CrossRef
17. The cyclical revival of psychedelics in psychiatric treatment
    Francisco J. Appiani et al, 2024, Current Medical Research and Opinion CrossRef
18. Profiling the combination of bupropion and dextromethorphan as a treatment option for major depressive disorder
    Joseph Blanco et al, 2024, Expert Review of Neurotherapeutics CrossRef
19. Effect of single intravenous injection of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial
    Bin Ling et al, 2023, BMC Pharmacology and Toxicology CrossRef
20. Ketamine and Nitrous Oxide
    Alvin M. Janski et al, 2024, Reference Module in Neuroscience and Biobehavioral Psychology CrossRef
21. Therapeutic management of atypical antipsychotic‑related metabolic dysfunctions using GLP‑1 receptor agonists: A systematic review
    Octavian Vasiliu, 2023, Experimental and Therapeutic Medicine CrossRef
22. The Psychiatric, Psychological, and Psychotherapeutic Approach to Erectile Dysfunction – Between Good Practices and Clinical Challenges
    null null et al, 2024, Romanian Journal of Military Medicine CrossRef
23. Research Progress of Esketamine in Improving Perioperative Depression and Sleep Quality
    永旭 高, 2024, Advances in Clinical Medicine CrossRef